EphA2-targeted CAR-T cell therapy
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for EphA2-targeted CAR-T cell therapy, covering 2025-05-15 to 2025-05-15. Get the full timeline:
Most recent: Clinical Trial Update: Clinical Study of Combined EphA2-targeted CAR-DC and CAR-T Cell Therapy for Non-small Cell Lung Cancer [Phase 1]